[
  "Seo Jung-jin is cofounder of Celltrion, a biopharmaceutical firm that makes drugs to treat cancer, influenza and rheumatoid arthritis, among others.",
  "In January 2020, Seo announced he will step down as chairman of Celltrion and retire by the end of the year.",
  "With expectations for biosimilars high in South Korea, his Celltrion has become a favorite among investors. ",
  "Seo started the firm in 2002 and took it public in 2008. \r\n",
  "His marketing subsidiary, Celltrion Healthcare, went public on the KOSDAQ in July 2017. "
]